Histone deacetylase inhibitors: discovery and development as anticancer agents (Q34470150)

From Wikidata

Jump to navigation Jump to search

The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.

scientific article

Language	Label	Description	Also known as
English	Histone deacetylase inhibitors: discovery and development as anticancer agents	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

1 reference

Europe PubMed Central

Histone deacetylase inhibitors: discovery and development as anticancer agents (English)

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

author name string

Paul A Marks

1

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Milos Dokmanovic

2

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

language of work or name

0 references

publication date

1 December 2005

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Expert Opinion on Investigational Drugs

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

14

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

12

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

1497-1511

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Histone acetyltransferases and deacetylases in the control of cell proliferation and differentiation

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.12.1497

21 January 2018

Histone deacetylases and cancer: causes and therapies

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.12.1497

21 January 2018

Binary switches and modification cassettes in histone biology and beyond.

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.12.1497

21 January 2018

An increasingly complex code

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.12.1497

21 January 2018

Transcription regulation by histone methylation: interplay between different covalent modifications of the core histone tails

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.12.1497

21 January 2018

Controlling the double helix

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.12.1497

21 January 2018

The nucleosome: from genomic organization to genomic regulation

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.12.1497

21 January 2018

Histone and chromatin cross-talk

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.12.1497

21 January 2018

Histone deacetylases (HDACs): characterization of the classical HDAC family

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.12.1497

21 January 2018

The Sir2 family of protein deacetylases

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.12.1497

21 January 2018

Epigenetic and chromatin modifiers as targeted therapy of hematologic malignancies

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.12.1497

21 January 2018

Molecular evolution of the histone deacetylase family: functional implications of phylogenetic analysis.

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.12.1497

21 January 2018

Clinical development of histone deacetylase inhibitors as anticancer agents

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.12.1497

21 January 2018

Histone deacetylase inhibitors in cancer therapy: is transcription the primary target?

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.12.1497

21 January 2018

Acetylation of proteins as novel target for antitumor therapy: review article.

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.12.1497

21 January 2018

The histone deacetylase inhibitor SAHA arrests cancer cell growth, up-regulates thioredoxin-binding protein-2, and down-regulates thioredoxin.

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.12.1497

21 January 2018

Histone deacetylase (HDAC) inhibitor activation of p21WAF1 involves changes in promoter-associated proteins, including HDAC1

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.12.1497

21 January 2018

Regulation of histone deacetylase activities

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.12.1497

21 January 2018

Cloning and characterization of a histone deacetylase, HDAC9

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.12.1497

21 January 2018

Class II histone deacetylases: versatile regulators

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.12.1497

21 January 2018

Regulation of histone deacetylase 4 and 5 and transcriptional activity by 14-3-3-dependent cellular localization

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.12.1497

21 January 2018

HDAC6 regulates Hsp90 acetylation and chaperone-dependent activation of glucocorticoid receptor

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.12.1497

21 January 2018

The deacetylase HDAC6 regulates aggresome formation and cell viability in response to misfolded protein stress

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.12.1497

21 January 2018

Cloning and characterization of the murine histone deacetylase (HDAC3).

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.12.1497

21 January 2018

Three proteins define a class of human histone deacetylases related to yeast Hda1p

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.12.1497

21 January 2018

HDAC7, a thymus-specific class II histone deacetylase, regulates Nur77 transcription and TCR-mediated apoptosis

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.12.1497

21 January 2018

Isolation and characterization of mammalian HDAC10, a novel histone deacetylase

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.12.1497

21 January 2018

Cloning and functional characterization of HDAC11, a novel member of the human histone deacetylase family

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.12.1497

21 January 2018

Histone deacetylase 4 controls chondrocyte hypertrophy during skeletogenesis

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.12.1497

21 January 2018

Histone deacetylases 5 and 9 govern responsiveness of the heart to a subset of stress signals and play redundant roles in heart development

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.12.1497

21 January 2018

Class II histone deacetylases act as signal-responsive repressors of cardiac hypertrophy

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.12.1497

21 January 2018

Chicken histone deacetylase-2 controls the amount of the IgM H-chain at the steps of both transcription of its gene and alternative processing of its pre-mRNA in the DT40 cell line

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.12.1497

21 January 2018

Role of Class I and Class II histone deacetylases in carcinoma cells using siRNA

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.12.1497

21 January 2018

Induction of HDAC2 expression upon loss of APC in colorectal tumorigenesis

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.12.1497

21 January 2018

N-terminal region, C-terminal region, nuclear export signal, and deacetylation activity of histone deacetylase-3 are essential for the viability of the DT40 chicken B cell line

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.12.1497

21 January 2018

Caspase-mediated specific cleavage of human histone deacetylase 4.

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.12.1497

21 January 2018

Histone deacetylase inhibitors in clinical development

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.12.1497

21 January 2018

Expression profile of histone deacetylase 1 in gastric cancer tissues.

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.12.1497

21 January 2018

Upregulation and nuclear recruitment of HDAC1 in hormone refractory prostate cancer

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.12.1497

21 January 2018

Antibody response to a non-conserved C-terminal part of human histone deacetylase 3 in colon cancer patients

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.12.1497

21 January 2018

Reduced expression of class II histone deacetylase genes is associated with poor prognosis in lung cancer patients.

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.12.1497

21 January 2018

HDAC6 expression is correlated with better survival in breast cancer.

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.12.1497

21 January 2018

PPARdelta is an APC-regulated target of nonsteroidal anti-inflammatory drugs

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.12.1497

21 January 2018

Prediction of prognosis of estrogen receptor-positive breast cancer with combination of selected estrogen-regulated genes

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.12.1497

21 January 2018

Histone Deacetylase Inhibitors

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.12.1497

21 January 2018

A class of hybrid polar inducers of transformed cell differentiation inhibits histone deacetylases.

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.12.1497

21 January 2018

Novel histone deacetylase inhibitors: cyclic tetrapeptide with trifluoromethyl and pentafluoroethyl ketones

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.12.1497

21 January 2018

Histone Deacetylase Inhibitors: The Abbott Experience

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.12.1497

21 January 2018

Histone deacetylase inhibitors: understanding a new wave of anticancer agents

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.12.1497

21 January 2018

Class I histone deacetylase-selective novel synthetic inhibitors potently inhibit human tumor proliferation

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.12.1497

21 January 2018

Domain-selective small-molecule inhibitor of histone deacetylase 6 (HDAC6)-mediated tubulin deacetylation

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.12.1497

21 January 2018

Structures of a histone deacetylase homologue bound to the TSA and SAHA inhibitors

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.12.1497

21 January 2018

Structural snapshots of human HDAC8 provide insights into the class I histone deacetylases

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.12.1497

21 January 2018

Transcriptional signature of histone deacetylase inhibition in multiple myeloma: biological and clinical implications

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.12.1497

21 January 2018

Deacetylase activity is required for recruitment of the basal transcription machinery and transactivation by STAT5.

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.12.1497

21 January 2018

Histone acetylation-mediated regulation of genes in leukaemic cells.

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.12.1497

21 January 2018

Histone deacetylase inhibitor selectively induces p21WAF1 expression and gene-associated histone acetylation

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.12.1497

21 January 2018

Specific and redundant functions of histone deacetylases in regulation of cell cycle and apoptosis

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.12.1497

21 January 2018

Histone deacetylase inhibitors specifically kill nonproliferating tumour cells

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.12.1497

21 January 2018

Role of thioredoxin in the response of normal and transformed cells to histone deacetylase inhibitors

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.12.1497

21 January 2018

Apoptotic and autophagic cell death induced by histone deacetylase inhibitors

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.12.1497

21 January 2018

The role of the redox protein thioredoxin in cell growth and cancer

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.12.1497

21 January 2018

Antioxidant function of thioredoxin and glutaredoxin systems

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.12.1497

21 January 2018

Regulation of the mammalian selenoprotein thioredoxin reductase 1 in relation to cellular phenotype, growth, and signaling events.

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.12.1497

21 January 2018

Physiological functions of thioredoxin and thioredoxin reductase

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.12.1497

21 January 2018

Cotreatment with histone deacetylase inhibitor LAQ824 enhances Apo-2L/tumor necrosis factor-related apoptosis inducing ligand-induced death inducing signaling complex activity and apoptosis of human acute leukemia cells

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.12.1497

21 January 2018

Biology of chronic myeloid leukemia and possible therapeutic approaches to imatinib-resistant disease

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.12.1497

21 January 2018

FR901228, an inhibitor of histone deacetylases, increases the cellular responsiveness to IL-6 type cytokines by enhancing the expression of receptor proteins

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.12.1497

21 January 2018

T-cell lymphoma as a model for the use of histone deacetylase inhibitors in cancer therapy: impact of depsipeptide on molecular markers, therapeutic targets, and mechanisms of resistance

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.12.1497

21 January 2018

Drug insight: Histone deacetylase inhibitors--development of the new targeted anticancer agent suberoylanilide hydroxamic acid

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.12.1497

21 January 2018

Treatment of myelodysplastic syndromes with valproic acid alone or in combination with all-trans retinoic acid

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.12.1497

21 January 2018

Prospects: histone deacetylase inhibitors

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.12.1497

21 January 2018

Identifiers

10.1517/13543784.14.12.1497

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34470150&oldid=1551890196"